Opana ER

Shares of Endo International plc - Ordinary Shares (NASDAQ: ENDP) were trading lower by more than 10 percent Friday morning in reaction to the U.S. Food and Drug Administration's request for the company to withdraw from the market its opioid painkiller called Opana ER. Stifel's Annabel Samimy felt...

Depomed Inc (NASDAQ: DEPO) and activist investor Starboard Value reached an agreement which will see the drugmaker name a new CEO and add two new members to its board. Despite the latest developments, analysts at Cantor Fitzgerald aren't ready to name the stock as a buy just yet. In a report...

In its biopharma catalysts tracker released March 1, Leerink termed the year 2017 as a busy one for Neuro and Oncology. The firm highlighted the important catalysts for 2017. Celgene — Multiple Readout In 2017 On Celgene Corporation (NASDAQ: CELG), the firm noted that it has multiple readouts...

The U.S. Food and Drug Administration reached a conclusion this week concerning Endo International plc - Ordinary Shares (NASDAQ: ENDP)'s therapy Opana ER, which is intended to treat pain severe enough to require a daily, around-the-clock, long-term opioid treatment. An independent FDA panel...

“After two days of data presentations, the FDA Advisory Committee voted 18-8 (1 abstention) that the benefits of reformulated, crush-resistant Opana ER no longer outweigh the risks,” Cantor Fitzgerald’s Chiara Russo said in a note. The analyst maintained an Overweight rating on...

The Federal Trade Commission refiled complaints against multiple drug companies Monday for their efforts to block generic competitors of branded products. Endo Pharma And International In one case, the FTC filed an antitrust suit against Endo Pharmaceuticals Inc. and Endo International plc -...

Although Impax Laboratories Inc (NASDAQ: IPXL)'s prospects have improved since the remediation of its manufacturing issues in 2015, Goldman Sachs’ Stephan Stewart believes “the fundamental outlook is fully reflected in the stock,” and there could be “increased competition...